These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21948767)

  • 1. Synergistic effect of resveratrol and quercetin released from drug-eluting polymer coatings for endovascular devices.
    Kleinedler JJ; Foley JD; Alexander JS; Roerig SC; Hebert VY; Dugas TR
    J Biomed Mater Res B Appl Biomater; 2011 Nov; 99(2):266-75. PubMed ID: 21948767
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Arterial pharmacokinetics of red wine polyphenols: implications for novel endovascular therapies targeting restenosis.
    Kleinedler JJ; Pjescic I; Bullock KK; Khaliq A; Foley JD; Dugas TR
    J Pharm Sci; 2012 May; 101(5):1917-31. PubMed ID: 22359273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol and quercetin interact to inhibit neointimal hyperplasia in mice with a carotid injury.
    Khandelwal AR; Hebert VY; Kleinedler JJ; Rogers LK; Ullevig SL; Asmis R; Shi R; Dugas TR
    J Nutr; 2012 Aug; 142(8):1487-94. PubMed ID: 22718033
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel nanocomposite stent coating releasing resveratrol and quercetin reduces neointimal hyperplasia and promotes re-endothelialization.
    Kleinedler JJ; Foley JD; Orchard EA; Dugas TR
    J Control Release; 2012 Apr; 159(1):27-33. PubMed ID: 22269665
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of Peroxisome Proliferator-Activated Receptor-δ as Novel Therapeutic Strategy to Prevent In-Stent Restenosis and Stent Thrombosis.
    Hytönen J; Leppänen O; Braesen JH; Schunck WH; Mueller D; Jung F; Mrowietz C; Jastroch M; von Bergwelt-Baildon M; Kappert K; Heuser A; Drenckhahn JD; Pieske B; Thierfelder L; Ylä-Herttuala S; Blaschke F
    Arterioscler Thromb Vasc Biol; 2016 Aug; 36(8):1534-48. PubMed ID: 27283742
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro and in vivo characterization of novel biodegradable polymers for application as drug-eluting stent coatings.
    Lockwood NA; Hergenrother RW; Patrick LM; Stucke SM; Steendam R; Pacheco E; Virmani R; Kolodgie FD; Hubbard B
    J Biomater Sci Polym Ed; 2010; 21(4):529-52. PubMed ID: 20233507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The behavior of vascular smooth muscle cells and platelets onto epigallocatechin gallate-releasing poly(l-lactide-co-epsilon-caprolactone) as stent-coating materials.
    Cho HH; Han DW; Matsumura K; Tsutsumi S; Hyon SH
    Biomaterials; 2008 Mar; 29(7):884-93. PubMed ID: 18031806
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of thrombin-induced signaling by resveratrol and quercetin: effects on adenosine nucleotide metabolism in endothelial cells and platelet-neutrophil interactions.
    Kaneider NC; Mosheimer B; Reinisch N; Patsch JR; Wiedermann CJ
    Thromb Res; 2004; 114(3):185-94. PubMed ID: 15342215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells.
    Mertens-Talcott SU; Percival SS
    Cancer Lett; 2005 Feb; 218(2):141-51. PubMed ID: 15670891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synergy study of the inhibitory potential of red wine polyphenols on vascular smooth muscle cell proliferation.
    Kurin E; Atanasov AG; Donath O; Heiss EH; Dirsch VM; Nagy M
    Planta Med; 2012 May; 78(8):772-8. PubMed ID: 22499559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-eluting stent coatings.
    Puskas JE; Muñoz-Robledo LG; Hoerr RA; Foley J; Schmidt SP; Evancho-Chapman M; Dong J; Frethem C; Haugstad G
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2009; 1(4):451-62. PubMed ID: 20049810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relaxant and antioxidant capacity of the red wine polyphenols, resveratrol and quercetin, on isolated mice corpora cavernosa.
    Boydens C; Pauwels B; Decaluwé K; Brouckaert P; Van de Voorde J
    J Sex Med; 2015 Feb; 12(2):303-12. PubMed ID: 25443137
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design, preparation and performance of a novel drug-eluting stent with multiple layer coatings.
    Hu T; Lin S; Du R; Fu M; Rao Q; Yin T; Huang Y; Wang G
    Biomater Sci; 2017 Aug; 5(9):1845-1857. PubMed ID: 28676873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. New stent surface materials: the impact of polymer-dependent interactions of human endothelial cells, smooth muscle cells, and platelets.
    Busch R; Strohbach A; Rethfeldt S; Walz S; Busch M; Petersen S; Felix S; Sternberg K
    Acta Biomater; 2014 Feb; 10(2):688-700. PubMed ID: 24148751
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug eluting stents based on Poly(ethylene carbonate): optimization of the stent coating process.
    Bege N; Steinmüller SO; Kalinowski M; Reul R; Klaus S; Petersen H; Curdy C; Janek J; Kissel T
    Eur J Pharm Biopharm; 2012 Apr; 80(3):562-70. PubMed ID: 22209978
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of antioxidants, resveratrol, quercetin, and N-acetylcysteine, on the functions of cultured rat hepatic stellate cells and Kupffer cells.
    Kawada N; Seki S; Inoue M; Kuroki T
    Hepatology; 1998 May; 27(5):1265-74. PubMed ID: 9581680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Biodegradable, elastomeric coatings with controlled anti-proliferative agent release for magnesium-based cardiovascular stents.
    Gu X; Mao Z; Ye SH; Koo Y; Yun Y; Tiasha TR; Shanov V; Wagner WR
    Colloids Surf B Biointerfaces; 2016 Aug; 144():170-179. PubMed ID: 27085049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Controlled delivery of paclitaxel from stent coatings using novel styrene maleic anhydride copolymer formulations.
    Richard R; Schwarz M; Chan K; Teigen N; Boden M
    J Biomed Mater Res A; 2009 Aug; 90(2):522-32. PubMed ID: 18563805
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Resveratrol attenuates adenosine diphosphate-induced platelet activation by reducing protein kinase C activity.
    Yang YM; Wang XX; Chen JZ; Wang SJ; Hu H; Wang HQ
    Am J Chin Med; 2008; 36(3):603-13. PubMed ID: 18543392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vasorelaxing activity of resveratrol and quercetin in isolated rat aorta.
    Chen CK; Pace-Asciak CR
    Gen Pharmacol; 1996 Mar; 27(2):363-6. PubMed ID: 8919657
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.